ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Infectious Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,256Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 69

$1.3M Total Retail Price of All Prescriptions

Rank: 4 out of 69

406 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 406 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 7,320 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 44%.

Prescription Price

$115 was the average price of a prescription from this provider, compared to $222 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
PRAVASTATIN SODIUM 440 319 1 16
LISINOPRIL 435 266 2 2
OMEPRAZOLE 427 253 3 3
CARVEDILOL 343 306 4 38
SIMVASTATIN 328 246 5 1
FUROSEMIDE 291 245 6 9
AMLODIPINE BESYLATE 271 219 7 6
LOSARTAN POTASSIUM 261 222 8 36
LEVOTHYROXINE SODIUM 259 219 9 7
METFORMIN HCL 253 176 10 12
CRESTOR 228 113 11 31
ZOLPIDEM TARTRATE 207 164 12 28
HYDROCHLOROTHIAZIDE 201 155 13 10
HYDROCODONE-ACETAMINOPHEN 199 158 S3 14 26
SPIRIVA 189 105 15 46
ALENDRONATE SODIUM 171 146 16 30
METOPROLOL SUCCINATE 170 135 17 21
ATORVASTATIN CALCIUM 141 95 18 19
TRUVADA 141 13 18 4
METOPROLOL TARTRATE 133 107 20 14
SERTRALINE HCL 121 69 21 39
GLIMEPIRIDE 118 92 22 45
WARFARIN SODIUM 109 71 23 20
NORVIR 104 0 24 5
CITALOPRAM HBR 103 40 25 23
TRAMADOL HCL 102 41 26 22
PREDNISONE 98 73 27 56
EPZICOM 90 17 28 43
DOXYCYCLINE HYCLATE 90 71 28 83
RANITIDINE HCL 90 42 28 65
TAMSULOSIN HCL 89 52 31 41
PROAIR HFA 88 46 32 24
ATENOLOL 85 58 33 13
TRAZODONE HCL 85 39 33 27
GABAPENTIN 84 51 35 15
ISENTRESS 79 22 36 11
DILTIAZEM 24HR ER 79 47 36 101
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 39 38 52
AZITHROMYCIN 72 47 39 47
SPIRONOLACTONE 69 55 40 48
ATRIPLA 64 12 41 8
ALLOPURINOL 63 50 42 35
FLUTICASONE PROPIONATE 62 38 43 55
IBUPROFEN 61 20 44 40
TRICOR 60 0 45 121
ACETAMINOPHEN-CODEINE 59 33 S3 46 88
OXYCODONE-ACETAMINOPHEN 56 11 S2 47 29
METFORMIN HCL ER 56 36 47 77
NABUMETONE 55 28 49 85
ONGLYZA 54 37 50 129
DIGOXIN 53 42 51 51
LEVOFLOXACIN 51 27 52 92
TRAMADOL HCL-ACETAMINOPHEN 50 49 53 140
CELEBREX 50 34 53 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.